iKena Oncology gains following workforce reduction, review of alternatives
PremiumThe FlyiKena Oncology gains following workforce reduction, review of alternatives
5M ago
iKena discontinues IK-930 and reduces workforce by 53%, to review alternatives
Premium
The Fly
iKena discontinues IK-930 and reduces workforce by 53%, to review alternatives
5M ago
iKena Oncology reports Q1 EPS (33c), consensus (41c)
Premium
The Fly
iKena Oncology reports Q1 EPS (33c), consensus (41c)
6M ago
Ikena Oncology Announces Leadership Change and Strategic Shift
PremiumCompany AnnouncementsIkena Oncology Announces Leadership Change and Strategic Shift
9M ago
Ikena Oncology Inc trading resumes
Premium
The Fly
Ikena Oncology Inc trading resumes
10M ago
iKena cuts 35% of workforce to focus on IK-930 and IK-595, to extend runway
Premium
The Fly
iKena cuts 35% of workforce to focus on IK-930 and IK-595, to extend runway
10M ago
iKena Oncology shares initial dose escalation data from IK-930 Phase 1 trial
PremiumThe FlyiKena Oncology shares initial dose escalation data from IK-930 Phase 1 trial
12M ago
Wedbush starts iKena Oncology at Outperform with positive outlook on pipeline
Premium
The Fly
Wedbush starts iKena Oncology at Outperform with positive outlook on pipeline
1y ago
iKena Oncology initiated with an Outperform at Wedbush
Premium
The Fly
iKena Oncology initiated with an Outperform at Wedbush
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100